Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements5743Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4871Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
10635 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 5743

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Ablation Treatment with FARAPULSE™ Pulsed Field Ablation (PFA) System… NCT07925359 · NAVigate-ULTRA — The Evaluation of User Experience With FARAVIEW™ Technology of… Maladie coronarienne À vérifier Non applicable NOT_YET_RECRUITING The objective of this study is to obtain experience with new and modified… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
SESAME Procedure NCT07806149 · NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective… Maladie coronarienne Traitement symptomatique Non applicable NOT_YET_RECRUITING This is an early study of a catheter-based minimally invasive procedure ca… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Topical cyanoacrylate tissue adhesive NCT07926191 · Tissue Adhesive Versus Figure-of-Eight Suture for Femoral Venous Closure After E… Maladie coronarienne Thérapie génique À vérifier NOT_YET_RECRUITING In July 2026 the electrophysiology laboratory of a Czech tertiary cardiolo… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Truvaga Plus NCT07926945 · U54: nVNS RCT — Effects of nVNS on Stress Reactivity in IBS Maladie coronarienne Traitement symptomatique Non applicable NOT_YET_RECRUITING Irritable bowel syndrome (IBS) is a chronic disorder of gut-brain interact… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Capstan Compass Robotic System for Transcatheter Mitral Valve Replace… NCT07917208 · Early Feasibility Study of the Capstan Medical TMVR System Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This early feasibility study is evaluating the safety and performance of t… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Discontinuation of aspirin (ATC-code B01AC06 and N02BA01) NCT07854795 · RELEASE-Norway — Reconsidering Long-Term Apirin in the Elderly in Secondary Prev… Maladie coronarienne À vérifier Phase 4 NOT_YET_RECRUITING Lifelong aspirin has been a cornerstone of secondary prevention after coro… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Extracorporeal Shock Wave Therapy NCT07068399 · CSWT — Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronar… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This randomized single-blind controlled trial aims to compare the effectiv… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Modified ultrafiltration NCT00246779 · A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Su… Maladie coronarienne À vérifier Non applicable COMPLETED Cardiac surgery is a major consumer of blood products worldwide. The natur… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Naproxen NCT07549490 · Human Experimental Models of Pain (HEMP) Maladie coronarienne Immunomodulation · Traitement symptomatique Non applicable NOT_YET_RECRUITING This pilot study will test an innovative way to establish how pain medicin… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Prescription of Aspirin NCT07524335 · ASCAD-P — Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Con… Maladie coronarienne À vérifier Phase 3 RECRUITING In patients with subclinical coronary artery disease, the ASCAD-P study ai… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Pulmonary Vein Isolation NCT06402617 · RETRO-AF — Ablation of Focal Activation in Atrial Fibrillation Maladie coronarienne Ralentissement de la progression Non applicable RECRUITING Atrial Fibrillation (AF) and Heart Failure (HF) are colliding global cardi… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Serratus Posterior Superior Intercostal Plane Block With Bupivacaine NCT07588230 · Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardia… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This randomized, double-blind, placebo-controlled study aims to evaluate t… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
TAVI NCT07926022 · TAVI and PCI in Comparison to SAVR and CABG in Low and Intermediate Risk Patient… Maladie coronarienne À vérifier À vérifier RECRUITING \# WHAT IS THIS STUDY ABOUT? This study compares two different treatment a… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
This study involved an auxillary CE-marked medical device (implantabl… NCT07545512 · ODISSEY — ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Car… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING Although advances in treatment and patient management have considerably im… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Evolocumab NCT05284747 · EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Maladie coronarienne À vérifier Phase 4 ACTIVE_NOT_RECRUITING The primary objective of this study is to evaluate the effectiveness of ea… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
Microaxial flow pump (left ventricular assist device) NCT07762560 · DOUBLE-SHOCK — Routine Microaxial Heart Pump Support and Protocolized Pulmonary… Maladie coronarienne Thérapie génique Non applicable RECRUITING The goal of this clinical trial is to learn which treatment strategies imp… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
No aspirin (Prasugurel monotherapy) NCT05709626 · PREMIUM — PRasugrEl Monotherapy Following prImary percUtaneous Coronary Interven… Maladie coronarienne À vérifier Phase 4 COMPLETED The aim of this study is to evaluate the safety of prasugrel monotherapy w… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
Percutaneous Mechanical Circulatory Support NCT06445608 · PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm Maladie coronarienne À vérifier Non applicable RECRUITING This purpose of this trial is to demonstrate 30 day safety and effectivene… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
26G Needle NCT07926113 · MASS-NEEDLE — Comparison of 26G and 30G Needles for Masseter Trigger Point Injec… Myopathies Traitement symptomatique Non applicable NOT_YET_RECRUITING This randomized split-face study aims to compare the effects of 26G and 30… À vérifier ClinicalTrials.gov 2026-11-09 21:02:59 Détail
ABSK021 NCT04192344 · A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in… Myopathies À vérifier Phase 1 RECRUITING This is an open-label phase 1 study to determine the safety and tolebility… À vérifier ClinicalTrials.gov 2026-11-09 21:02:59 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4871

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Non-Pharmacological Treatments of Migraine: Current Evidence and Clin… Aerobic exercise · PMID 42484949 Migraine Ralentissement de la progression · Traitement symptomatique Publication PubMed Voir la publication source Non-pharmacological migraine treatments are commonly used for prevention, may be preferred in sensitive groups such as… Current pain and headache reports 2026-07-22 21:20:28 Source
Pyridoxine/pyridoxal-5'-phosphate repletion to improve outcomes of al… Metabolic Cofactor Supplementation · PMID 42480097 Maladie d’Alzheimer · Maladie de Parkinson · Maladie de Parkinson Traitement symptomatique Publication PubMed Voir la publication source Deficiency of pyridoxal-5-phosphate, the clinically measured and active form of pyridoxine (vitamin B6), is prevalent a… Clinical toxicology (Philadelphia, Pa.) 2026-07-22 21:20:24 Source
Deep brain stimulation for the treatment of patients with dystonia: a… Non Invasive Neuromodulation for Patients With Motor Control Disorders · PMID 42456686 Maladie de Parkinson Ralentissement de la progression Publication PubMed Voir la publication source Dystonia is a complex movement disorder that can cause functional disability and reduce quality of life. Deep brain sti… The Lancet. Neurology 2026-07-22 21:20:23 Source
Increased brain glucose metabolism after anodal left DLPFC-right shou… Anodal Transcranial direct current stimulation · PMID 42477631 Migraine · Sclérose en plaques · Migraine Traitement symptomatique Publication PubMed Voir la publication source Anodal transcranial direct current stimulation (tDCS) using an extracephalic montage has demonstrated clinical efficacy… BMC psychiatry 2026-07-22 21:20:12 Source
Prefrontal transcranial direct current stimulation in alcohol use dis… Anodal Transcranial direct current stimulation · PMID 42475940 Migraine · Sclérose en plaques · Migraine Traitement symptomatique Publication PubMed Voir la publication source Alcohol Use Disorder (AUD) is a frequent and often treatment-resistant condition, with high relapse rates and frequent… Addictive behaviors 2026-07-22 21:20:12 Source
Distribution of human platelet antigen genotypes in Lithuanian blood… Platelet transfusion · PMID 42475659 Sclérose en plaques À vérifier Publication PubMed Voir la publication source Human platelet antigens (HPAs) are polymorphic structures on platelet membrane glycoproteins that may induce alloimmune… Blood transfusion = Trasfusione del sangue 2026-07-22 21:20:11 Source
Transfusion Support After CAR-T Cell Therapy: Real-World Patterns Acr… Platelet transfusion · PMID 42471153 Sclérose en plaques Thérapie cellulaire Publication PubMed Voir la publication source Chimeric antigen receptor (CAR) T-cell therapy is frequently complicated by prolonged cytopenias requiring transfusion.… Transfusion clinique et biologique : journal de la Soc… 2026-07-22 21:20:11 Source
Microglial suppression by myeloperoxidase inhibitor does not delay ne… Verdiperstat · PMID 39674307 Maladie de Parkinson · Sclérose en plaques · Sclérose latérale amyotr… Remyélinisation indirecte / réparation · Ralentissement de la progression · Imm… Publication PubMed Voir la publication source Drugs able to efficiently counteract the progression of multiple sclerosis (MS) are still an unmet need. Numerous precl… Experimental neurology 2026-07-22 21:20:07 Source
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Rando… Verdiperstat · PMID 40067754 Sclérose latérale amyotrophique Neuroprotection · Ralentissement de la progression · Immunomodulation Publication PubMed Voir la publication source Myeloperoxidase is one of the most abundant peroxidase enzymes in activated myeloid cells. Myeloperoxidase inhibitors m… JAMA neurology 2026-07-22 21:20:07 Source
French guidelines for the diagnosis and management of neuromyelitis o… spinal cord MRI follow-up · PMID 42481362 Sclérose en plaques Ralentissement de la progression · Traitement symptomatique Publication PubMed Voir la publication source Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system, characterized by… Revue neurologique 2026-07-22 21:20:03 Source
Suspected ruptured medulla oblongata abscess treated conservatively w… spinal cord MRI follow-up · PMID 42482548 Sclérose en plaques Traitement symptomatique Publication PubMed Voir la publication source Brainstem abscess is a rare and serious condition that requires intensive medical treatment whenever a suggestive diagn… The Journal of international medical research 2026-07-22 21:20:03 Source
Identification of (20R)-protopanaxadiol from Panax ginseng as a novel… Ginseng · PMID 42482536 Sclérose en plaques À vérifier Publication PubMed Voir la publication source COVID-19 remains a global health concern, yet current antivirals are restricted to high-risk patients and face issues o… FEBS open bio 2026-07-22 21:19:45 Source
Metabolic engineering of tobacco for heterologous production of rare… Ginseng · PMID 42483519 Sclérose en plaques À vérifier Publication PubMed Voir la publication source Rare ginsenosides, such as compound K (CK) and Rh2, possess potent pharmacological activities but are present at extrem… Frontiers in plant science 2026-07-22 21:19:45 Source
Clinical and cost-effectiveness of the iStep-MS physical activity and… Ambulation Study in Multiple Sclerosis · PMID 42476739 Sclérose en plaques Ralentissement de la progression · Traitement symptomatique · Thérapie génique Publication PubMed Voir la publication source Regular physical activity and limiting sedentary behaviour are important aspects in managing multiple sclerosis (MS). F… BMJ open 2026-07-22 21:19:43 Source
18F-PBR06 PET/CT imaging for evaluating atherosclerotic plaques linke… [18F]PBR06 · PMID 30875334 Sclérose latérale amyotrophique À vérifier Publication PubMed Voir la publication source The present study explored the 18 kDa translocator protein radioligand [F]N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phen… Nuclear medicine communications 2026-07-18 15:48:49 Source
Impact of Sexuality in Patients With Motor Neuron Disease. Mac2ALS — Expression Profile Study of Macrophages From Patients Affected by ALS or Other Relat… Sclérose latérale amyotrophique Ralentissement de la progression · Traitement symptomatique Publication PubMed Voir la publication source Sexuality is a relevant yet understudied aspect in people living with motor neuron disease (MND). This study aimed to a… Muscle & nerve 2026-07-18 15:48:49 Source
Key principles for rehabilitation of critically ill patients with obe… Mac2ALS — Expression Profile Study of Macrophages From Patients Affected by ALS or Other Relat… Sclérose latérale amyotrophique À vérifier Publication PubMed Voir la publication source Patients with obesity who are admitted to an ICU bring specific challenges for rehabilitation during and after critical… Intensive care medicine 2026-07-18 15:48:49 Source
Widespread Glial Activation in Primary Progressive Multiple Sclerosis… [18F]PBR06 · PMID 33208611 Sclérose en plaques Ralentissement de la progression · Immunomodulation Publication PubMed Voir la publication source A 64-year-old man with primary progressive multiple sclerosis (Expanded Disability Status Scale 3.5) underwent PET usin… Clinical nuclear medicine 2026-07-18 15:48:49 Source
SPG302 mitigates diabetic retinal neuropathy and inner retinal damage… Tazbentetol · PMID 42456876 Sclérose latérale amyotrophique À vérifier Publication PubMed Voir la publication source Diabetic retinopathy (DR) is a leading cause of vision loss stemming from vascular and neurodegenerative sequelae of im… Experimental eye research 2026-07-18 15:48:47 Source
Effects of respiratory muscle training on respiratory function in pat… Respiratory Complications in ALS · PMID 42455190 Sclérose latérale amyotrophique À vérifier Publication PubMed Voir la publication source Respiratory decline is prognostically important in amyotrophic lateral sclerosis (ALS), but the efficacy of respiratory… Journal of neurology 2026-07-18 15:48:46 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.